{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T09:09:11Z","timestamp":1754557751789},"reference-count":70,"publisher":"Termedia Sp. z.o.o.","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Med Sci"],"published-print":{"date-parts":[[2021,5,6]]},"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Obstruction of the ureter may occur due to congenital, iatrogenic or other reasons. This can cause hydronephrosis in the early stage and can lead to cellular inflammation, necrosis and atrophy in the kidney tissue. The aim of this paper is to evaluate the protective effect of pheniramine maleate (PM) and zofenopril on renal damage caused by hydronephrosis due to unilateral partial ureter obstruction.<\/jats:p><\/jats:sec><jats:sec><jats:title>Material and methods<\/jats:title><jats:p>Twenty-four female Sprague Dawley rats were divided into 4 groups. Group 1: sham group, group 2: partial unilateral ureteral obstruction (PUUO) group, group 3: PUUO + PM group, group 4: PUUO + zofenopril group. Paraoxonase (PON), total antioxidant status (TAS) and total oxidant status (TOS) of tissue and blood samples were measured and calculated. Tissue samples were evaluated histopathologically.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>An increase in tissue TAS and a decrease in tissue TOS and OSI levels were detected in groups 3 and 4 compared to group 2 (both: p &lt; 0.01). Tissue PON levels showed an increase in groups 3 and 4 compared to groups 1 and 2 (both: p &lt; 0.01). Histopathological evaluation showed a decrease in interstitial inflammation and congestion in groups 3 and 4 compared to the control group (p &lt; 0.001). The decrease was observed to be more significant in group 4 compared to group 3 (p &lt; 0.01).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In our experimental study, we observed that PM and zofenopril reduce the oxidation and tissue damage caused by unilateral partial obstruc\u00adtion.<\/jats:p><\/jats:sec>","DOI":"10.5114\/aoms.2019.88320","type":"journal-article","created":{"date-parts":[[2019,10,11]],"date-time":"2019-10-11T22:48:43Z","timestamp":1570834123000},"page":"812-817","source":"Crossref","is-referenced-by-count":2,"title":["Evaluation of pheniramine maleate and zofenopril in reducing renal damage induced by unilateral ureter obstruction. An experimental study"],"prefix":"10.5114","volume":"17","author":[{"given":"Ercan","family":"Yuvanc","sequence":"first","affiliation":[{"name":"Department of Urology, Kirikkale University School of Medicine, Kirikkale, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devrim","family":"Tuglu","sequence":"additional","affiliation":[{"name":"Department of Urology, Kirikkale University School of Medicine, Kirikkale, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tunc","family":"Ozan","sequence":"additional","affiliation":[{"name":"Department of Urology, Firat University School of Medicine, Elazig, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ucler","family":"Kisa","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Kirikkale University School of Medicine, Kirikkale, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahi","family":"Balci","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kirikkale University School of Medicine, Kirikkale, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ertan","family":"Batislam","sequence":"additional","affiliation":[{"name":"Department of Urology, Kirikkale University School of Medicine, Kirikkale, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erdal","family":"Yilmaz","sequence":"additional","affiliation":[{"name":"Department of Urology, Kirikkale University School of Medicine, Kirikkale, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3061","published-online":{"date-parts":[[2021,5,6]]},"reference":[{"key":"ref-518997","unstructured":". (). https:\/\/www.worldometers.info\/coronavirus\/#countries. (Accessed: 18.12.2020)."},{"key":"ref-518998","unstructured":". (). https:\/\/coronavirus.jhu.edu\/. (Accessed: 18.12.2020)."},{"key":"ref-518999","unstructured":". (). https:\/\/www.worldometers.info\/world-population\/. (Accessed: 18.12.2020)."},{"key":"ref-519000","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.15585\/mmwr.mm6950e2","article-title":"The Advisory Committee on Immunization Practices\u2019 Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine \u2013 United States, December 2020","volume":"69","author":"Oliver SE","year":"2020","unstructured":"Oliver SE, Gargano JW, Marin M, et al. (2020). The Advisory Committee on Immunization Practices\u2019 Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine \u2013 United States, December 2020 MMWR Morb Mortal Wkly Rep. 69: 1922-4.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref-519001","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey M","year":"2021","unstructured":"Voysey M, Clemens SAC, Madhi SA, et al. (2021). Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK Lancet. 397: 99-111.","journal-title":"Lancet"},{"key":"ref-519002","unstructured":". (). https:\/\/www.bbc.co.uk\/news\/world-us-canada-55358334. (Accessed: 18.12.2020)."},{"key":"ref-519003","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1002\/ptr.6738","article-title":"Potential effects of curcumin in the treatment of COVID-19 infection","volume":"34","author":"Zahedipour F","year":"2020","unstructured":"Zahedipour F, Hosseini SA, Sathyapalan T, et al. (2020). Potential effects of curcumin in the treatment of COVID-19 infection Phytother Res. 34: 2911-20.","journal-title":"Phytother Res"},{"key":"ref-519004","doi-asserted-by":"crossref","first-page":"104891","DOI":"10.1016\/j.phrs.2020.104891","article-title":"Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic","volume":"158","author":"Banach M","year":"2020","unstructured":"Banach M, Penson PE, Fras Z, et al. (2020). Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic Pharmacol Res. 158: 104891.","journal-title":"Pharmacol Res"},{"key":"ref-519005","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang C","year":"2020","unstructured":"Huang C, Wang Y, Li X, et al. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Lancet. 395: 497-506.","journal-title":"Lancet"},{"key":"ref-519006","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1007\/s10900-020-00920-x","article-title":"Prevalence and associated risk factors of mortality among COVID-19 patients: a meta- analysis","volume":"45","author":"Noor FM","year":"2020","unstructured":"Noor FM, Islam MM. (2020). Prevalence and associated risk factors of mortality among COVID-19 patients: a meta- analysis J Commun Health. 45: 1270-82.","journal-title":"J Commun Health"},{"key":"ref-519007","doi-asserted-by":"publisher","DOI":"10.1159\/000512592"},{"key":"ref-519008","doi-asserted-by":"crossref","first-page":"e0243600","DOI":"10.1371\/journal.pone.0243600","article-title":"Metabolic risk factors and risk of Covid-19: a systematic review and meta-analysis","volume":"15","author":"Moazzami B","year":"2020","unstructured":"Moazzami B, Chaichian S, Kasaeian A, et al. (2020). Metabolic risk factors and risk of Covid-19: a systematic review and meta-analysis PLoS One. 15: e0243600.","journal-title":"PLoS One"},{"key":"ref-519009","doi-asserted-by":"crossref","first-page":"575600","DOI":"10.3389\/fphys.2020.575600","article-title":"Pathophysiology of cardiovascular complications in COVID-19","volume":"11","author":"Petrovic V","year":"2020","unstructured":"Petrovic V, Radenkovic D, Radenkovic G, Djordjevic V, Banach M. (2020). Pathophysiology of cardiovascular complications in COVID-19 Front Physiol. 11: 575600.","journal-title":"Front Physiol"},{"key":"ref-519010","doi-asserted-by":"crossref","first-page":"e2029058","DOI":"10.1001\/jamanetworkopen.2020.29058","article-title":"Risk factors associated with in-hospital mortality in a US national sample of patients with COVID-19","volume":"3","author":"Rosenthal N","year":"2020","unstructured":"Rosenthal N, Cao Z, Gundrum J, Sianis J, Safo S. (2020). Risk factors associated with in-hospital mortality in a US national sample of patients with COVID-19 JAMA Network Open. 3: e2029058-e.","journal-title":"JAMA Network Open"},{"key":"ref-519011","doi-asserted-by":"crossref","first-page":"e22521","DOI":"10.2196\/22521","article-title":"Associations of medications with lower odds of typical COVID-19 symptoms: cross-sectional symptom surveillance study","volume":"6","author":"Urbach D","year":"2020","unstructured":"Urbach D, Awiszus F, Lei\u00df S, Venton T, De Specht AV, Apfelbacher C. (2020). Associations of medications with lower odds of typical COVID-19 symptoms: cross-sectional symptom surveillance study JMIR Public Health Surveill. 6: e22521.","journal-title":"JMIR Public Health Surveill"},{"key":"ref-519012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13063-020-04840-y","article-title":"Atorvastatin and aspirin as adjuvant therapy in patients with SARS-CoV-2 infection: a structured summary of a study protocol for a randomised controlled trial","volume":"21","author":"Ghati N","year":"2020","unstructured":"Ghati N, Roy A, Bhatnagar S, et al. (2020). Atorvastatin and aspirin as adjuvant therapy in patients with SARS-CoV-2 infection: a structured summary of a study protocol for a randomised controlled trial Trials. 21: 1-3.","journal-title":"Trials"},{"key":"ref-519013","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/j.dsx.2020.10.021","article-title":"Statins and SARS-CoV-2 disease: current concepts and possible benefits","volume":"14","author":"Minz MM","year":"2020","unstructured":"Minz MM, Bansal M, Kasliwal RR. (2020). Statins and SARS-CoV-2 disease: current concepts and possible benefits Diabetes Metab Syndr. 14: 2063-7.","journal-title":"Diabetes Metab Syndr"},{"key":"ref-519014","doi-asserted-by":"crossref","first-page":"154375","DOI":"10.1016\/j.metabol.2020.154375","article-title":"Commentary: statins, COVID-19, and coronary artery disease: killing two birds with one stone","volume":"113","author":"Ganjali S","year":"2020","unstructured":"Ganjali S, Bianconi V, Penson PE, et al. (2020). Commentary: statins, COVID-19, and coronary artery disease: killing two birds with one stone Metabolism. 113: 154375.","journal-title":"Metabolism"},{"key":"ref-519015","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1160\/th15-08-0620","article-title":"The impact of statin therapy on plasma levels of von Willebrand factor antigen: systematic review and meta-analysis of randomised placebo-controlled trials","volume":"115","author":"Sahebkar A","year":"2016","unstructured":"Sahebkar A, Serban C, Ursoniu S, et al. (2016). The impact of statin therapy on plasma levels of von Willebrand factor antigen: systematic review and meta-analysis of randomised placebo-controlled trials Thromb Haemost. 115: 520-32.","journal-title":"Thromb Haemost"},{"key":"ref-519016","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.amjcard.2020.10.026","article-title":"More good news on statins and COVID-19","volume":"138","author":"Katsiki N","year":"2020","unstructured":"Katsiki N, Banach M, Mikhailidis DP. (2020). More good news on statins and COVID-19 Am J Cardiol. 138: 127-8.","journal-title":"Am J Cardiol"},{"key":"ref-519017","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.3390\/jcm9061909","article-title":"Cholesterol in relation to COVID-19: should we care about it?","volume":"9","author":"Radenkovic D","year":"2020","unstructured":"Radenkovic D, Chawla S, Pirro M, Sahebkar A, Banach M. (2020). Cholesterol in relation to COVID-19: should we care about it? J Clin Med. 9: 1909.","journal-title":"J Clin Med"},{"key":"ref-519018","first-page":"248","article-title":"Cardiovascular disease: C-reactive protein and the inflammatory disease paradigm: HMG-CoA reductase inhibitors, alpha-tocopherol, red yeast rice, and olive oil polyphenols. A review of the literature","volume":"6","author":"Patrick L","year":"2001","unstructured":"Patrick L, Uzick M. (2001). Cardiovascular disease: C-reactive protein and the inflammatory disease paradigm: HMG-CoA reductase inhibitors, alpha-tocopherol, red yeast rice, and olive oil polyphenols. A review of the literature Altern Med Rev. 6: 248-71.","journal-title":"Altern Med Rev"},{"key":"ref-519019","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s11745-010-3517-x","article-title":"Simvastatin therapy reduces prooxidant-antioxidant balance: results of a placebo-controlled cross-over trial","volume":"46","author":"Parizadeh SM","year":"2011","unstructured":"Parizadeh SM, Azarpazhooh MR, Moohebati M, et al. (2011). Simvastatin therapy reduces prooxidant-antioxidant balance: results of a placebo-controlled cross-over trial Lipids. 46: 333-40.","journal-title":"Lipids"},{"key":"ref-519020","doi-asserted-by":"crossref","first-page":"9902","DOI":"10.1038\/srep09902","article-title":"A systematic review and meta-analysis of the effect of statins on plasma asymmetric dimethylarginine concentrations","volume":"5","author":"Serban C","year":"2015","unstructured":"Serban C, Sahebkar A, Ursoniu S, et al. (2015). A systematic review and meta-analysis of the effect of statins on plasma asymmetric dimethylarginine concentrations Sci Rep. 5: 9902.","journal-title":"Sci Rep"},{"key":"ref-519021","doi-asserted-by":"crossref","first-page":"105735","DOI":"10.1016\/j.biocel.2020.105735","article-title":"Statins reduce vascular inflammation in atherogenesis: a review of underlying molecular mechanisms","volume":"122","author":"Liberale L","year":"2020","unstructured":"Liberale L, Carbone F, Montecucco F, Sahebkar A. (2020). Statins reduce vascular inflammation in atherogenesis: a review of underlying molecular mechanisms Int J Biochem Cell Biol. 122: 105735.","journal-title":"Int J Biochem Cell Biol"},{"key":"ref-519022","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/dom.12386","article-title":"Using real-world data to evaluate the association of incretin-based therapies with risk of acute pancreatitis: a meta-analysis of 1 324 515 patients from observational studies","volume":"17","author":"Wang T","year":"2015","unstructured":"Wang T, Wang F, Gou Z, et al. (2015). Using real-world data to evaluate the association of incretin-based therapies with risk of acute pancreatitis: a meta-analysis of 1 324 515 patients from observational studies Diabetes Obes Metab. 17: 32-41.","journal-title":"Diabetes Obes Metab"},{"key":"ref-519023","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s40279-014-0194-6","article-title":"What are the main risk factors for running-related injuries?","volume":"44","author":"Saragiotto BT","year":"2014","unstructured":"Saragiotto BT, Yamato TP, Junior LCH, Rainbow MJ, Davis IS, Lopes AD. (2014). What are the main risk factors for running-related injuries? Sports Med. 44: 1153-63.","journal-title":"Sports Med"},{"key":"ref-519024","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"62","author":"Liberati A","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, et al. (2009). The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration J Clin Epidemiol. 62: e1-34.","journal-title":"J Clin Epidemiol"},{"key":"ref-519025","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/(SICI)1097-0258(19960330)15:6<619::AID-SIM188>3.0.CO;2-A","article-title":"A likelihood approach to meta- analysis with random effects","volume":"15","author":"Hardy RJ","year":"1996","unstructured":"Hardy RJ, Thompson SG. (1996). A likelihood approach to meta- analysis with random effects Stat Med. 15: 619-29.","journal-title":"Stat Med"},{"key":"ref-519026","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins JP","year":"2002","unstructured":"Higgins JP, Thompson SG. (2002). Quantifying heterogeneity in a meta-analysis Stat Med. 21: 1539-58.","journal-title":"Stat Med"},{"key":"ref-519027","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger M","year":"1997","unstructured":"Egger M, Smith GD, Schneider M, Minder C. (1997). Bias in meta-analysis detected by a simple, graphical test BMJ. 315: 629-34.","journal-title":"BMJ"},{"key":"ref-519028","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg CB","year":"1994","unstructured":"Begg CB, Mazumdar M. (1994). Operating characteristics of a rank correlation test for publication bias Biometrics. 50: 1088-101.","journal-title":"Biometrics"},{"key":"ref-519029","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","article-title":"Trim and fill: a simple funnel-plot\u2013based method of testing and adjusting for publication bias in meta-analysis","volume":"56","author":"Duval S","year":"2000","unstructured":"Duval S, Tweedie R. (2000). Trim and fill: a simple funnel-plot\u2013based method of testing and adjusting for publication bias in meta-analysis Biometrics. 56: 455-63.","journal-title":"Biometrics"},{"key":"ref-519030","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13045-020-00934-x","article-title":"A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forward","volume":"13","author":"Wang B","year":"2020","unstructured":"Wang B, Van Oekelen O, Mouhieddine TH, et al. (2020). A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forward J Hematol Oncol. 13: 94.","journal-title":"J Hematol Oncol"},{"key":"ref-519031","doi-asserted-by":"crossref","first-page":"110005","DOI":"10.1016\/j.jclinane.2020.110005","article-title":"Clinical comorbidities, characteristics, and outcomes of mechanically ventilated patients in the State of Michigan with SARS-CoV-2 pneumonia","volume":"67","author":"Krishnan S","year":"2020","unstructured":"Krishnan S, Patel K, Desai R, et al. (2020). Clinical comorbidities, characteristics, and outcomes of mechanically ventilated patients in the State of Michigan with SARS-CoV-2 pneumonia J Clin Anesth. 67: 110005.","journal-title":"J Clin Anesth"},{"key":"ref-519032","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.dsx.2020.07.011","article-title":"Pros and cons for use of statins in people with coronavirus disease-19 (COVID-19)","volume":"14","author":"Subir R","year":"2020","unstructured":"Subir R, Jagat JM, Kalyan KG. (2020). Pros and cons for use of statins in people with coronavirus disease-19 (COVID-19) Diabetes Metab Syndr. 14: 1225-9.","journal-title":"Diabetes Metab Syndr"},{"key":"ref-519033","first-page":"100751","article-title":"Statins-based prophylactic mouthwash and nasal spray may protect against coronavirus disease 2019","volume":"37","author":"Abdulrab S","year":"2020","unstructured":"Abdulrab S, Alkadasi B, Al-Maweri S, Halboub E, Alhadainy H, Geerts G. (2020). Statins-based prophylactic mouthwash and nasal spray may protect against coronavirus disease 2019 New Microbes New Infect. 37: 100751.","journal-title":"New Microbes New Infect"},{"key":"ref-519034","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s10753-017-0668-4","article-title":"Experimental study of the protective effect of simvastatin on lung injury in rats with sepsis","volume":"41","author":"Wang Y","year":"2018","unstructured":"Wang Y, Yang W, Zhao X, Zhang R. (2018). Experimental study of the protective effect of simvastatin on lung injury in rats with sepsis Inflammation. 41: 104-13.","journal-title":"Inflammation"},{"key":"ref-519035","doi-asserted-by":"crossref","first-page":"14652","DOI":"10.1038\/s41598-018-32376-4","article-title":"Simvastatin Protects cardiomyocytes against endotoxin-induced apoptosis and up-regulates survivin\/NF-\u03baB\/p65 expression","volume":"8","author":"Ne\u017ei\u0107 L","year":"2018","unstructured":"Ne\u017ei\u0107 L, \u0160krbi\u0107 R, Amid\u017ei\u0107 L, Gajanin R, Ku\u010da K, Ja\u0107evi\u0107 V. (2018). Simvastatin Protects cardiomyocytes against endotoxin-induced apoptosis and up-regulates survivin\/NF-\u03baB\/p65 expression Sci Rep. 8: 14652.","journal-title":"Sci Rep"},{"key":"ref-519036","first-page":"227","article-title":"Statins as early therapy to mitigate COVID-19 (SARS-CoV-2)-associated ARDS and cytokine storm syndrome - time is of the essence","volume":"5","author":"Teoh N","year":"2020","unstructured":"Teoh N, Farrell G. (2020). Statins as early therapy to mitigate COVID-19 (SARS-CoV-2)-associated ARDS and cytokine storm syndrome - time is of the essence J Clin Transl Res. 5: 227-9.","journal-title":"J Clin Transl Res"},{"key":"ref-519037","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.3389\/fimmu.2020.01648","article-title":"Cytokine storm in COVID-19 \u2013 immunopathological mechanisms, clinical considerations, and therapeutic approaches: the REPROGRAM consortium position paper","volume":"11","author":"Bhaskar S","year":"2020","unstructured":"Bhaskar S, Sinha A, Banach M, et al. (2020). Cytokine storm in COVID-19 \u2013 immunopathological mechanisms, clinical considerations, and therapeutic approaches: the REPROGRAM consortium position paper Front Immunol. 11: 1648.","journal-title":"Front Immunol"},{"key":"ref-519038","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/JCMA.0000000000000463","article-title":"Clinical manifestation and disease progression in COVID-19 infection","volume":"84","author":"Tsai PH","year":"2021","unstructured":"Tsai PH, Lai WY, Lin YY, et al. (2021). Clinical manifestation and disease progression in COVID-19 infection J Chin Med Assoc. 84: 3-8.","journal-title":"J Chin Med Assoc"},{"key":"ref-519039","doi-asserted-by":"crossref","first-page":"101054","DOI":"10.1016\/j.plipres.2020.101054","article-title":"Antiviral effects of statins","volume":"79","author":"Gorabi AM","year":"2020","unstructured":"Gorabi AM, Kiaie N, Bianconi V, et al. (2020). Antiviral effects of statins Prog Lipid Res. 79: 101054.","journal-title":"Prog Lipid Res"},{"key":"ref-519040","doi-asserted-by":"crossref","first-page":"490","DOI":"10.5114\/aoms.2020.94655","article-title":"Statins and the COVID-19 main protease: in silico evidence on direct interaction","volume":"16","author":"Reiner \u017d","year":"2020","unstructured":"Reiner \u017d, Hatamipour M, Banach M, et al. (2020). Statins and the COVID-19 main protease: in silico evidence on direct interaction Arch Med Sci. 16: 490-6.","journal-title":"Arch Med Sci"},{"key":"ref-519041","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.amjcard.2020.08.004","article-title":"Meta-analysis of effect of statins in patients with COVID-19","volume":"134","author":"Kow CS","year":"2020","unstructured":"Kow CS, Hasan SS. (2020). Meta-analysis of effect of statins in patients with COVID-19 Am J Cardiol. 134: 153-5.","journal-title":"Am J Cardiol"},{"key":"ref-519042","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1001\/jamainternmed.2020.3539","article-title":"Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy","volume":"180","author":"Grasselli G","year":"2020","unstructured":"Grasselli G, Greco M, Zanella A, et al. (2020). Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy JAMA Intern Med. 180: 1345-55.","journal-title":"JAMA Intern Med"},{"key":"ref-519043","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2047"},{"key":"ref-519044","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1007\/s11739-020-02504-y","article-title":"Protective role of statins in COVID 19 patients: importance of pharmacokinetic characteristics rather than intensity of action","volume":"15","author":"Rossi R","year":"2020","unstructured":"Rossi R, Talarico M, Coppi F, Boriani G. (2020). Protective role of statins in COVID 19 patients: importance of pharmacokinetic characteristics rather than intensity of action Intern Emerg Med. 15: 1573-6.","journal-title":"Intern Emerg Med"},{"key":"ref-519045","doi-asserted-by":"crossref","first-page":"101202","DOI":"10.1016\/j.diabet.2020.10.001","article-title":"Routine use of statins and increased COVID-19 related mortality in inpatients with type 2 diabetes: results from the CORONADO study","volume":"47","author":"Cariou B","year":"2021","unstructured":"Cariou B, Goronflot T, Rimbert A, et al. (2021). Routine use of statins and increased COVID-19 related mortality in inpatients with type 2 diabetes: results from the CORONADO study Diabetes Metab. 47: 101202.","journal-title":"Diabetes Metab"},{"key":"ref-519046","doi-asserted-by":"crossref","first-page":"e018475","DOI":"10.1161\/JAHA.120.018475","article-title":"Statin use and in-hospital mortality in diabetics with COVID-19","volume":"9","author":"Saeed O","year":"2020","unstructured":"Saeed O, Castagna F, Agalliu I, et al. (2020). Statin use and in-hospital mortality in diabetics with COVID-19 J Am Heart Assoc. 9: e018475.","journal-title":"J Am Heart Assoc"},{"key":"ref-519047","doi-asserted-by":"crossref","first-page":"e044421","DOI":"10.1136\/bmjopen-2020-044421","article-title":"Association between statin use and outcomes in patients with coronavirus disease 2019 (COVID-19): a nationwide cohort study","volume":"10","author":"Butt JH","year":"2020","unstructured":"Butt JH, Gerds TA, Schou M, et al. (2020). Association between statin use and outcomes in patients with coronavirus disease 2019 (COVID-19): a nationwide cohort study BMJ Open. 10: e044421.","journal-title":"BMJ Open"},{"key":"ref-519048","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.cmet.2020.06.015","article-title":"In-hospital use of statins is associated with a reduced risk of mortality among individuals with COVID-19","volume":"32","author":"Zhang XJ","year":"2020","unstructured":"Zhang XJ, Qin JJ, Cheng X, et al. (2020). In-hospital use of statins is associated with a reduced risk of mortality among individuals with COVID-19 Cell Metab. 32: 176-87.e4.","journal-title":"Cell Metab"},{"key":"ref-519049","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1186\/s13054-020-03154-4","article-title":"Atorvastatin associated with decreased hazard for death in COVID-19 patients admitted to an ICU: a retrospective cohort study","volume":"24","author":"Rodriguez-Nava G","year":"2020","unstructured":"Rodriguez-Nava G, Trelles-Garcia DP, Yanez-Bello MA, Chung CW, Trelles-Garcia VP, Friedman HJ. (2020). Atorvastatin associated with decreased hazard for death in COVID-19 patients admitted to an ICU: a retrospective cohort study Critical Care. 24: 429.","journal-title":"Critical Care"},{"key":"ref-519050","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-030-71697-4_17","article-title":"Association of in-hospital use of statins, aspirin and renin-angiotensin-aldosterone inhibitors with mortality and ICU admission due to COVID-19","author":"Vahedian-Azimi A","year":"2021","unstructured":"Vahedian-Azimi A, Rahimibashar F, Najafi A, et al. (2021). Association of in-hospital use of statins, aspirin and renin-angiotensin-aldosterone inhibitors with mortality and ICU admission due to COVID-19 Adv Exp Med Biol. .","journal-title":"Adv Exp Med Biol"},{"key":"ref-519051","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcvp\/pvaa128"},{"key":"ref-519052","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3390\/pathogens9090759","article-title":"Statin use is associated with decreased risk of invasive mechanical ventilation in COVID-19 patients: a preliminary study","volume":"9","author":"Song SL","year":"2020","unstructured":"Song SL, Hays SB, Panton CE, et al. (2020). Statin use is associated with decreased risk of invasive mechanical ventilation in COVID-19 patients: a preliminary study Pathogens. 9: 759.","journal-title":"Pathogens"},{"key":"ref-519053","doi-asserted-by":"crossref","first-page":"m1996","DOI":"10.1136\/bmj.m1996","article-title":"Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series","volume":"369","author":"Argenziano MG","year":"2020","unstructured":"Argenziano MG, Bruce SL, Slater CL, et al. (2020). Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series BMJ. 369: m1996.","journal-title":"BMJ"},{"key":"ref-519054","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.jamda.2020.06.018","article-title":"The effects of ARBs, ACEIs and statins on clinical outcomes of COVID-19 infection among nursing home residents","volume":"21","author":"De Spiegeleer","year":"2020","unstructured":"De Spiegeleer A, Bronselaer A, Teo JT, et al. (2020). The effects of ARBs, ACEIs and statins on clinical outcomes of COVID-19 infection among nursing home residents J Am Med Dir Assoc. 21: 909-914.e2.","journal-title":"J Am Med Dir Assoc"},{"key":"ref-519055","first-page":"271","article-title":"The characteristics of 50 hospitalized COVID-19 patients with and without ARDS","volume":"117","author":"Dreher M","year":"2020","unstructured":"Dreher M, Kersten A, Bickenbach J, et al. (2020). The characteristics of 50 hospitalized COVID-19 patients with and without ARDS Deutsches \u00c4rzteblatt International. 117: 271.","journal-title":"Deutsches \u00c4rzteblatt International"},{"key":"ref-519056","doi-asserted-by":"crossref","first-page":"17458","DOI":"10.1038\/s41598-020-74492-0","article-title":"Statin use is associated with lower disease severity in COVID-19 infection","volume":"10","author":"Tan WY","year":"2020","unstructured":"Tan WY, Young BE, Lye DC, Chew DE, Dalan R. (2020). Statin use is associated with lower disease severity in COVID-19 infection Sci Rep. 10: 17458.","journal-title":"Sci Rep"},{"key":"ref-519057","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.amjcard.2020.09.012","article-title":"Relation of statin use prior to admission to severity and recovery among COVID-19 inpatients","volume":"136","author":"Daniels LB","year":"2020","unstructured":"Daniels LB, Sitapati AM, Zhang J, et al. (2020). Relation of statin use prior to admission to severity and recovery among COVID-19 inpatients Am J Cardiol. 136: 149-55.","journal-title":"Am J Cardiol"},{"key":"ref-519058","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-56210\/v1"},{"key":"ref-519059","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2020.10.001"},{"key":"ref-519060","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-106030\/v1"},{"key":"ref-519061","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1007\/s11739-020-02504-y","article-title":"Protective role of statins in COVID 19 patients: importance of pharmacokinetic characteristics rather than intensity of action","volume":"15","author":"Rossi R","year":"2020","unstructured":"Rossi R, Talarico M, Coppi F, Boriani G. (2020). Protective role of statins in COVID 19 patients: importance of pharmacokinetic characteristics rather than intensity of action Intern Emerg Med. 15: 1573-76.","journal-title":"Intern Emerg Med"},{"key":"ref-519062","article-title":"Impact of hypertension on progression and prognosis in patients with COVID-19","author":"Zenga H","unstructured":"Zenga H, Zhang T, He X, et al. (). Impact of hypertension on progression and prognosis in patients with COVID-19 medRxiv. .","journal-title":"medRxiv"},{"key":"ref-519063","article-title":"Outcomes and cardiovascular comorbidities in a predominantly African-American population with COVID-19","author":"Nguyen AB","unstructured":"Nguyen AB, Upadhyay GA, Chung B, et al. (). Outcomes and cardiovascular comorbidities in a predominantly African-American population with COVID-19 medRxiv. .","journal-title":"medRxiv"},{"key":"ref-519064","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000513047","article-title":"Assessment of clinical characteristics and mortality-associated factors in COVID-19 critical cases in Kuwait","volume":"30","author":"Ayed M","year":"2021","unstructured":"Ayed M, Borahmah AA, Yazdani A, Sultan A, Mossad A, Rawdhan H. (2021). Assessment of clinical characteristics and mortality-associated factors in COVID-19 critical cases in Kuwait Medical Principles and Practice. 30: 185-92.","journal-title":"Medical Principles and Practice"},{"key":"ref-519065","article-title":"Estimating risk of mechanical ventilation and mortality among adult COVID-19 patients admitted to Mass General Brigham: the VICE and DICE Scores","author":"Nicholson CJ","unstructured":"Nicholson CJ, Wooster L, Sigurslid HH, et al. (). Estimating risk of mechanical ventilation and mortality among adult COVID-19 patients admitted to Mass General Brigham: the VICE and DICE Scores medRxiv [Preprint]. .","journal-title":"medRxiv [Preprint]"},{"key":"ref-519066","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jacc.2020.06.007","article-title":"Prevalence and impact of myocardial injury in patients hospitalized with COVID-19 infection","volume":"76","author":"Lala A","year":"2020","unstructured":"Lala A, Johnson KW, Januzzi JL, et al. (2020). Prevalence and impact of myocardial injury in patients hospitalized with COVID-19 infection J Am Coll Cardiol. 76: 533-46.","journal-title":"J Am Coll Cardiol"}],"container-title":["Archives of Medical Science"],"original-title":[],"link":[{"URL":"https:\/\/www.archivesofmedicalscience.com\/pdf-86713-64246","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.archivesofmedicalscience.com\/pdf-86713-64246","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T14:54:56Z","timestamp":1664636096000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.archivesofmedicalscience.com\/Evaluation-of-pheniramine-maleate-and-zofenopril-in-reducing-renal-damage-induced,86713,0,2.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,6]]},"references-count":70,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"alternative-id":["86713"],"URL":"https:\/\/doi.org\/10.5114\/aoms.2019.88320","relation":{},"ISSN":["1734-1922","1896-9151"],"issn-type":[{"value":"1734-1922","type":"print"},{"value":"1896-9151","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,6]]}}}